This marks a significant milestone as SIGX1094 is the first pipeline drug discovered using AI and organoid disease model to enter clinical trials, and the first targeted therapy candidate to ...

The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

Okomera is a biotech startup developing cutting-edge solutions for oncology drug discovery and will present their technology in SLAS 2025,in San Diego January 25 to 29, 2025. Okomera will showcase its ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

This marks a significant milestone as SIGX1094 is the first pipeline drug discovered using AI and organoid disease model to enter clinical trials, and the first targeted therapy candidate to address ...

Brain organoids developed in Israel for testing and repurposing a wide variety of existing drugs to see if they could treat ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

This organoid contains the three main types of pancreas ... studying these organoids could help develop regenerative therapies and new drugs to treat pancreatic diseases. "However, we first ...